Todos Medical Ltd. Operating Cash Flow
Todos Medical Ltd. reported Operating Cash Flow of -$1.87 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-14
- Todos Medical Ltd. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was $651.00K.
- Todos Medical Ltd. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$1.26M.
- Todos Medical Ltd. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$1.26M.
- Todos Medical Ltd. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$1.93M, a 273.58% decline year-over-year.
- Todos Medical Ltd. net cash provided by (used in) operating activities for fiscal 2021 was -$11.22M.
- Todos Medical Ltd. net cash provided by (used in) operating activities for fiscal 2020 was -$2.56M.
- Todos Medical Ltd. net cash provided by (used in) operating activities for fiscal 2019 was -$1.28M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | $651.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$609.00K derived: sum of 2 quarters · filed 2022-11-14 | -$1.87M 10-Q · filed 2022-11-14 | -$3.80M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | -$2.52M 10-Q · filed 2022-08-22 | -$4.45M derived: sum of 3 quarters · filed 2022-08-22 | -$7.76M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-03-31 | -$1.26M 10-Q · filed 2022-05-16 | -$3.19M derived: sum of 2 quarters · filed 2022-05-16 | -$6.50M derived: sum of 3 quarters · filed 2022-11-14 | -$9.31M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$5.23M derived: sum of 2 quarters · filed 2022-11-14 | -$8.04M derived: sum of 3 quarters · filed 2022-11-14 | -$11.22M 10-K · filed 2022-03-31 | |
| 2021-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.12M derived: sum of 2 quarters · filed 2022-11-14 | -$9.30M 10-Q · filed 2022-11-14 | -$8.19M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | -$5.99M 10-Q · filed 2022-08-22 | -$4.88M derived: sum of 3 quarters · filed 2022-08-22 | -$7.05M derived: sum of 4 quarters · filed 2022-08-22 | |
| 2021-03-31 | -$3.18M 10-Q · filed 2022-05-16 | -$2.07M derived: sum of 2 quarters · filed 2022-05-16 | -$4.24M derived: sum of 3 quarters · filed 2022-05-16 | -$5.06M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$1.06M derived: sum of 2 quarters · filed 2022-03-31 | -$1.88M derived: sum of 3 quarters · filed 2022-03-31 | -$2.56M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$2.99M derived: sum of 2 quarters · filed 2021-11-15 | -$3.67M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$820.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24 | -$1.50M 10-Q · filed 2021-09-24 | |||
| 2020-03-31 | -$675.00K 10-Q · filed 2021-06-22 | ||||
| 2019-12-31 | -$1.28M 10-K · filed 2021-04-21 | -$1.28M 20-F · filed 2020-06-15 | |||
| 2018-12-31 | -$1.06M 20-F/A · filed 2020-08-06 | ||||
| 2017-12-31 | -$904.41K 20-F/A · filed 2020-08-06 | ||||
| 2016-12-31 | -$469.39K 20-F · filed 2019-03-28 |